Thanks spotter. I see it on the Georgia Cigna list as tier 3. Is that for Georgia only or are they consistent with Cigna nationwide? In my neck of the woods, local provider Group Health has completed their Medicare Part D Abbreviated Reviews and made the following recommendation for action:
"Icosapent ethyl (Vascepa)
For the Reduction of Triglyceride Levels in Adult Patients With Severe Hypertriglyceridemia
Place in Tier 4 (Non-preferred Brand). At least 2 alternatives in preferred tier.."
Hi #$%$ _ spotter
I usually find you a credible source of info but I'm not finding Vascepa listed in Cigna's official 2013 formulary guide . I do see it listed on a type consumer guide broochure at Tier 3 however Medtrak maintains that once it is launched it will be non formulary initially.
So it would be good to get some clarity on that as pricing will be key to fending off the advance of high quality, lower cost , dietary supplements used as alternatives ( IMHO -the real cause in the decline in Lovaza sales )